1990
DOI: 10.1073/pnas.87.10.3982
|View full text |Cite
|
Sign up to set email alerts
|

Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.

Abstract: The alternative complement pathway is capable of discriminating human cells and tissues from a wide variety of potential pathogens. It has been recently demonstrated that attachment of complement component C3b to activator-derived molecules (e.g., small polysaccharides) restricts inactivation of C3b by factors H and I in a manner similar to activator surfaces. It is now shown that restriction is reversed by certain soluble polyanions (e.g., sialoglycopeptides, heparin, or dextran sulfate) that mimic the effect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
256
1
2

Year Published

1999
1999
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 357 publications
(264 citation statements)
references
References 42 publications
5
256
1
2
Order By: Relevance
“…These are Factor H regulates C3 and nucleosomes in apoptosis M Martin et al inhibitory receptors of the sialic acid-binding Ig-like lectin family, which attenuate immune responses and dampen inflammation. 27 FH binds to sialic acid 28 and seems to facilitate the interaction of cis sialic acids and siglec receptors on the monocytes, which enhances their inhibitory response.…”
Section: Discussionmentioning
confidence: 99%
“…These are Factor H regulates C3 and nucleosomes in apoptosis M Martin et al inhibitory receptors of the sialic acid-binding Ig-like lectin family, which attenuate immune responses and dampen inflammation. 27 FH binds to sialic acid 28 and seems to facilitate the interaction of cis sialic acids and siglec receptors on the monocytes, which enhances their inhibitory response.…”
Section: Discussionmentioning
confidence: 99%
“…Complement factor H was purified as described (17,18) and radiolabeled with Na 125 I (NEN, Boston, MA), according to the manufacturer's instructions. Free 125 I was separated from the labeled proteins by gel filtration through Sephadex G25 (Pharmacia).…”
Section: Binding Of Radiolabeled Factor H To H2 and U251 Cellsmentioning
confidence: 99%
“…Isopropyl alcohol-precipitated RNA was dissolved in diethylpyrocarbonate-treated water, and 1 g of RNA was denaturated at 70°C for 10 min and then immediately chilled on ice. Reverse-transcriptase reactions were conducted using RNA in a total volume of 20 l containing 10 mM DTT (Life Technologies), 500 M dNTP mix (Pharmacia), 25 g/ml oligo(dT) [12][13][14][15][16][17][18] (Pharmacia), and 200 U Moloney murine leukemia virus reverse transcriptase (Life Technologies) in a reverse-transcriptase buffer (Life Technologies). The reaction was allowed to occur for 1 h at 37°C.…”
Section: Rt-pcr Analysismentioning
confidence: 99%
“…AP attacks any surface that is not specifically protected against it (7); therefore, host cells need downregulation on their surfaces by plasma protein complement factor H (CFH) (8,9). CFH is composed of 20 domains; domains 1-4 mediate inactivation of deposited C3b or prevent C3b generation by accelerating decay of the C3-convertase C3bBb.…”
mentioning
confidence: 99%